Category Archives: Clinical Cardiology

Five members from the UBC Faculty of Medicine have been recognized with 2019 UBC faculty research awards for demonstrating excellence in research. Recipients include: UBC Killam Research Fellowships The fellowship enables faculty to pursue full-time research during a recognized study leave. Nick Bansback, School of Population and Public Health Dr Continue reading →

The resting heart rate refers to the number of times the heart beats per minute (bpm), pumping the least amount of blood needed while the body remains stationary. A new study said that a deviation from the resting heart rate of the person's regular baseline is considered a cause for concern, as it indicates an underlying health condition, such as hypothyroidism and medication overdose. A high resting heart rate (RHR) is generally considered a risk factor for developing cardiovascular disease, however, another previous study said that RHR below 65 bmp could also be problematic. Continue reading →

This market research report administers a broad view of the Nanomedicines market on a Global basis, presenting a forecast and statistics in terms of revenue during the forecast period. It covers an illustrative study with detailed segmentation, complete research and development history, latest news and press releases. Additionally, it demonstrates the future aspects and portrays a sketch of the key players involved in the markets growth in terms of revenue Continue reading →

Doctors and nurses routinely measure patients heart rates during clinical exams. If their heart rate falls outside of whats considered normal at a population level, it may be taken as a cause for concern. Continue reading →

A 70-year-old lady presents to her GP with recurrent fevers, fatigue, confusion and shortness of breath on exertion, which started a few weeks earlier. On examination she is febrile with a temperature of 38.4C. The GP notes that she has a newly discovered early diastolic heart murmur. Continue reading →

In January, Journalists Resource attended a four-day fellowship on cardiovascular health, Covering the Heart Beat, organized by the National Press Foundation. Researchers, physicians and journalists gathered with the goal of improving news coverage of cardiovascular health. Continue reading →

February 05, 2020 06:35 ET | Source: Meticulous Market Research Pvt. Ltd Continue reading →

EmboCube and Torpedo Safely and Effectively Help Physicians Control Bleeding and Hemorrhaging in the Peripheral Vasculature SOUTH JORDAN, Utah February 3, 2020 Merit Medical Systems, Inc. announced that both its EmboCube (syringe-loaded embolization gelatin foam) and Torpedo (uniform, pre-shaped gelatin foam loaded into a cartridge with optional blunt stylet) devices are now FDA indicated for the embolization of blood vessels to occlude blood flow, which helps control bleeding and hemorrhaging in the peripheral vasculature. EmboCube is the only gelatin foam that is delivered pre-cut and pre-loaded into a syringe for efficiency and ease of use Continue reading →

Coronary revascularization with PCI or CABG surgery results in comparable clinical outcomes at 10 years in patients with left main coronary artery disease and low-to-intermediate anatomic complexity, but there is a survival advantage with surgery in patients with the most complex anatomy, according to long-term follow-up of the MAIN-COMPARE registry. Led by Yong-Hoon Yoon, MD (Chungnam National University Hospital, Daejeon, South Korea), and published today in JACC: Cardiovascular Interventions, the investigators reported that for individuals with a low-to-intermediate SYNTAX score, all-cause mortality and the combined endpoint of death, MI, or stroke were not statistically different between patients treated with PCI or CABG surgery, although rates of target vessel revascularization were higher with PCI. Continue reading →

Hackensack Meridian Hackensack University Medical Center announced today that it is the first hospital in the U.S. to successfully implant the worlds first heart failure neuromodulation device, BAROSTIM NEO. This innovative technology is an effective alternative for patients with Congestive Heart Failure (CHF) who are ineligible for other forms of therapy such as Cardiac Resynchronization Therapy (CRT). Continue reading →